IPP Bureau
First procedure in India performed with Medtronic's Intellis spinal cord stimulator
By IPP Bureau - February 14, 2022
The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator
Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane
By IPP Bureau - February 14, 2022
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Avantor breaks ground on new distribution center to serve biopharmaceutical industry in Ireland
By IPP Bureau - February 14, 2022
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
Novartis India enters sales and distribution agreement with Dr. Reddy’s
By IPP Bureau - February 12, 2022
Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India
Cadila Pharma launches lotion to treat dry skin conditions
By IPP Bureau - February 11, 2022
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
Novavax Covid-19 vaccine well tolerated in paediatric population
By IPP Bureau - February 11, 2022
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
India’s first mRNA vaccine should be ready soon
By IPP Bureau - February 11, 2022
It is being developed by Pune-based Gennova Biopharmaceuticals
Zimmer Biomet opens customer experience centre in Singapore to drive robotics and MedTech
By IPP Bureau - February 11, 2022
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
.jpg "Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment"){kind=logo}
Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment
By IPP Bureau - February 11, 2022
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Marksans Pharma Q3FY22 PAT at Rs. 48.27 crore
By IPP Bureau - February 11, 2022
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
Amazon.in launches a storefront for Ayurveda products
By IPP Bureau - February 11, 2022
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
OPPI-QCI announce awards to celebrate excellence in manufacturing facility 2021
By IPP Bureau - February 11, 2022
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
X-Chem and Excelra's GOSTAR team up to discover drugs for challenging targets
By IPP Bureau - February 10, 2022
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
USFDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences
By IPP Bureau - February 10, 2022
Adds five years of market exclusivity on approval
Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel
By IPP Bureau - February 10, 2022
On track to complete the BLA submission in the first half of 2022
